. 2024 Jul 26;4:153. doi: 10.1038/s43856-024-00575-y

Table 2.

Treatment-Emergent Adverse Events

Variable	Overall (n = 36)	Placebo Pooled (n = 12)	AB002 1.5 µg/kg (n = 12)	AB002 3 µg/kg (n = 12)
Patients With TEAE	2 (6%)	1 (8%)	1 (8%)	0 (0%)
Patients Without TEAE	34 (94%)	11 (92%)	11 (92%)	12 (100%)
Number of TEAEs	3	1	2	0
AE^a / Severity^b / Relatedness		Hypotension / Grade 2 / Unlikely	Muscle spasms / Grade 1 / Unrelated Baclofen toxicity / Grade 3 / Unrelated

^aAEs are classified according to MedDRA version 21.1.

^bSeverity: Grade 1 = mild, Grade 2 = Moderate, Grade 3 = Severe, Grade 4 = Potentially life-threatening.